S&P 500 7,681.72 +0.76%
Nasdaq 26,189.55 +0.90%
S&P/TSX 36,008.67 +0.62%
Apple 345.72 −0.58%
Nvidia 215.83 +2.31%
Microsoft 529.21 +0.90%
Shopify 239.13 +1.22%
Royal Bank 283.16 +0.49%
CAD/USD 0.7120 −0.30%
LIVE · 10:45 ET
Market ClerkRecap
Mon Oct 26 · markets open1 signal today94 insider buys this week · $48.3MCIRO short report next: Oct 31The week ahead
KP
INSIDER · GRCE · Grace Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Kohli Prashant

Every open-market transaction filed under this name, Sep 9 to Sep 9.

Filings
1
1 buy · 0 sells
Bought
$214K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−9.3%
avg move from buy price, 1 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 9GRCEGrace Therapeutics, Inc.Chief Executive OfficerBuy100,000$2.14$214K−9.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.